These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8646002

  • 1. [-Effect of endogenous opioids on adrenal cortex activity in women with hypothalamic amenorrhea-].
    Krause BT, Möller S.
    Gynakol Geburtshilfliche Rundsch; 1995; 35(4):194-8. PubMed ID: 8646002
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity.
    Nappi RE, Petraglia F, Genazzani AD, D'Ambrogio G, Zara C, Genazzani AR.
    Fertil Steril; 1993 Mar; 59(3):571-6. PubMed ID: 8384575
    [Abstract] [Full Text] [Related]

  • 3. [The influence of endogenous opioids in hypothalamic amenorrhea. Diagnostic and therapeutic aspects].
    Krause B, Möller S, Ulrich U, Göretzlehner G.
    Zentralbl Gynakol; 1989 Mar; 111(20):1368-73. PubMed ID: 2555982
    [Abstract] [Full Text] [Related]

  • 4. Naloxone stimulation test in women with hypothalamic amenorrhea: a preliminary report.
    Krause B, Møller S, Göretzlehner G, Ulrich U, Matuszewski F, Wodrig W, Weber A.
    Exp Clin Endocrinol; 1992 Mar; 99(2):113-5. PubMed ID: 1322310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Possibility of ovulation induction using naloxone in women with hypothalamic amenorrhea].
    Krause B, Möller S, Göretzlehner G.
    Zentralbl Gynakol; 1991 Mar; 113(22):1221-33. PubMed ID: 1661461
    [Abstract] [Full Text] [Related]

  • 7. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.
    Facchinetti F, Fioroni L, Martignoni E, Sances G, Costa A, Genazzani AR.
    Psychosom Med; 1994 Mar; 56(5):418-22. PubMed ID: 7809341
    [Abstract] [Full Text] [Related]

  • 8. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ, Rasio E, Serri O.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [Abstract] [Full Text] [Related]

  • 12. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 13. Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans.
    Nye EJ, Bornstein SR, Grice JE, Tauchnitz R, Hockings GI, Strakosch CR, Jackson RV, Torpy DJ.
    J Neuroendocrinol; 2000 Feb; 12(2):141-5. PubMed ID: 10718909
    [Abstract] [Full Text] [Related]

  • 14. [The hypothalamus-hypophysis-adrenal system in patients with lactorrhea-amenorrhea syndrome].
    Oleĭnik VA, Luchitskiĭ EV, Valueva GV.
    Probl Endokrinol (Mosk); 1989 Feb; 35(5):14-8. PubMed ID: 2555814
    [Abstract] [Full Text] [Related]

  • 15. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Scott LV, Burnett F, Medbak S, Dinan TG.
    Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
    [Abstract] [Full Text] [Related]

  • 16. Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.
    Guido M, Ciampelli M, Fulghesu AM, Pavone V, Barini A, de Marinis L, Cento R, Caruso A, Lanzone A.
    Fertil Steril; 1999 Mar; 71(3):462-7. PubMed ID: 10065783
    [Abstract] [Full Text] [Related]

  • 17. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
    Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ.
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypercortisolism in patients with functional hypothalamic-amenorrhea.
    Suh BY, Liu JH, Berga SL, Quigley ME, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):733-9. PubMed ID: 3346352
    [Abstract] [Full Text] [Related]

  • 20. Endocrine actions of opioids.
    Pfeiffer A, Herz A.
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.